These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9916314)

  • 21. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
    Rockich K; Blouin R
    Drug Metab Dispos; 1999 Sep; 27(9):1074-7. PubMed ID: 10460809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
    Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
    J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.
    Lucas D; Berthou F; Girre C; Poitrenaud F; Ménez JF
    J Chromatogr; 1993 Dec; 622(1):79-86. PubMed ID: 8120116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry.
    Wu JY; Yue J; Feng YQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):260-6. PubMed ID: 21196134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
    Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
    Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans.
    Bachmann K; Sarver JG
    Pharmacology; 1996 Mar; 52(3):169-77. PubMed ID: 8849486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Drug Metab Dispos; 1998 May; 26(5):483-9. PubMed ID: 9571230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
    Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
    Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in microsomal activity in alcoholism and obesity.
    de la Maza MP; Hirsch S; Petermann M; Suazo M; Ugarte G; Bunout D
    Alcohol Clin Exp Res; 2000 May; 24(5):605-10. PubMed ID: 10832901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
    Mizuno D; Tanaka E; Tanno K; Misawa S
    Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
    Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
    Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
    Leclercq I; Desager JP; Horsmans Y
    Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography--mass spectrometry.
    Eap CB; Schnyder C; Savary L
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):139-44. PubMed ID: 9498681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
    Frye RF; Stiff DD
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):291-6. PubMed ID: 8971612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
    Kwon MH; Lee CJ; Cho YY; Kang HE
    J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.